Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Exagen Inc.

NASDAQ: XGN · Industrial Applications and Services · 8 alerts · CIK 1274737

Share price
$3.77Close, Nov 16
Market cap
$96.2M
Shares outstanding
25.51MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Exagen Inc. filings on SEC EDGAR ↗

9:02 AM ET 10-Q
Financial Results

Exagen Q3 2026 Results: Net Loss of $6.34M, Loss Narrows

Exagen Inc. reported revenue of $18.4 million for Q3 2026, a 6.8% increase year-over-year, while narrowing its net loss to $6.3 million compared to $7.1 million in Q3 2025. The company strengthened its capital position through $6.4 million in net proceeds from an at-the-market (ATM) equity offering during the quarter.

Key figure
Net loss $6.34M
7:33 AM ET 8-K
Financial Results

Exagen Financial Results

Exagen Inc. reported third quarter 2026 revenue of $18.4 million, a 7% increase year-over-year, driven by growth in test volume and average selling price. The company reduced its net loss to $6.3 million for the quarter and reiterated its full-year 2026 revenue guidance of $72 million to $75 million.

Term
Q3 2026

“Our third quarter extends what is fast becoming a record year for Exagen, and our ability to execute against our vision is increasingly evident in the results. The team grew the business again, with test volume and ASP both ahead of the same period last year.”

John Aballi, President and Chief Executive Officer of Exagen

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.